Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 15.09M
March 31, 2026 -16.14M
December 31, 2025 -29.03M
September 30, 2025 -41.30M
June 30, 2025 -32.46M
March 31, 2025 -28.39M
December 31, 2024 -8.858M
September 30, 2024 2.677M
June 30, 2024 3.648M
March 31, 2024 4.025M
December 31, 2023 -4.872M
September 30, 2023 -0.9704M
June 30, 2023 -0.0031M
March 31, 2023 -0.4047M
December 31, 2022 -1.859M
Date Value
September 30, 2022 -3.986M
June 30, 2022 -6.434M
March 31, 2022 -6.759M
December 31, 2021 -6.354M
September 30, 2021 -8.016M
June 30, 2021 -7.036M
March 31, 2021 -6.059M
December 31, 2020 -5.658M
September 30, 2020 -5.285M
June 30, 2020 -3.817M
March 31, 2020 -3.091M
December 31, 2019 -3.469M
September 30, 2019 -2.18M
June 30, 2019 -2.18M
March 31, 2019 -1.639M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Bicycle Therapeutics Plc 55.79M
Biodexa Pharmaceuticals Plc -0.1719M
argenx SE 4.673B
Mereo BioPharma Group Plc -1.195M
Evaxion AS 0.00